Important role of ventromedial hypothalamic carnitine palmitoyltransferase-1a in the control of food intake

Autor: Dolors Serra, Gary D. Lopaschuk, Wendy Keung, Su Gao, Fausto G. Hegardt
Přispěvatelé: Universitat de Barcelona
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Male
endocrine system diseases
Physiology
Endocrinology
Diabetes and Metabolism

Rats
Sprague-Dawley

chemistry.chemical_compound
Eating
heterocyclic compounds
Arc (protein)
Hipotàlem
Carnitina palmitoïl-transferasa 1
Fasting
Dependovirus
Malonyl Coenzyme A
Hypothalamus
medicine.drug
medicine.medical_specialty
endocrine system
Blotting
Western

Genetic Vectors
Fisiologia
Biology
Arcuate nucleus
Physiology (medical)
Internal medicine
Orexigenic
Brain Nucleus
Carnitine
Appetite Depressants
medicine
Animals
Hypoglycemic Agents
neoplasms
Nutrició
Injections
Intraventricular

Nutrition
Carnitine O-Palmitoyltransferase
Body Weight
Arcuate Nucleus of Hypothalamus
digestive system diseases
Rats
Enzyme Activation
Endocrinology
chemistry
Ventromedial Hypothalamic Nucleus
Anorectic
Epoxy Compounds
Carnitine palmitoyltransferase I
Acyl Coenzyme A
Etomoxir
Zdroj: Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Popis: Carnitine palmitoyltransferase-1 (CPT-1) liver isoform, or CPT-1a, is implicated in CNS control of food intake. However, the exact brain nucleus site(s) in mediating this action of CPT-1a has not been identified. In this report, we assess the role of CPT-1a in hypothalamic ventromedial nucleus (VMN). We stereotaxically injected an adenoviral vector containing CPT-1a coding sequence into the VMN of rats to induce overexpression and activation of CPT-1a. The VMN-selective activation of CPT-1a induced an orexigenic effect, suggesting CPT-1a in the VMN is involved in the central control of feeding. Intracerebroventricular administration of etomoxir, a CPT-1 inhibitor, decreases food intake. Importantly, in the animals with VMN overexpression of a CPT-1a mutant that antagonizes the CPT-1 inhibition by etomoxir, the anorectic response to etomoxir was attenuated. This suggests that VMN is involved in mediating the anorectic effect of central inhibition of CPT-1a. In contrast, arcuate nucleus (Arc) overexpression of the mutant did not alter etomoxir-induced inhibition of food intake, suggesting that Arc CPT-1a does not play significant roles in this anorectic action. Furthermore, in the VMN, CPT-1a appears to act downstream of hypothalamic malonyl-CoA action of feeding. Finally, we show that in the VMN CPT-1 activity was altered in concert with fasting and refeeding states, supporting a physiological role of CPT-1a in mediating the control of feeding. All together, CPT-1a in the hypothalamic VMN appears to play an important role in central control of food intake. VMN-selective modulation of CPT-1a activity may therefore be a promising strategy in controlling food intake and maintaining normal body weight.
Databáze: OpenAIRE